Last update:

Arthritis & Rheumatism news

Arthritis & Rheumatism

Clinical test predicts best rheumatoid arthritis treatment on first try

1 in 100 people in Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the body's immune system attacking its own joints. RA can strike quickly at any age—but ...

Arthritis & Rheumatism

Protein target could control chronic inflammation without affecting acute response

Chronic inflammation occurs when the immune system is stuck in attack-mode, sending cell after cell to defend and repair the body for months or even years. Diseases associated with chronic inflammation, like arthritis or ...

Arthritis & Rheumatism

The many ways that AI enters rheumatology

Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from data, identify patterns, and make decisions. But how can it be used to support health care? EULAR—The ...

Arthritis & Rheumatism

Osteoarthritis: Too many non-evidence-based therapies?

Osteoarthritis is a leading cause of chronic pain, often affecting physical function, daily activities, and quality of life. EULAR—The European Alliance of Associations for Rheumatology—has developed recommendations and ...

Arthritis & Rheumatism

Exploring patient experiences in juvenile idiopathic arthritis

Adolescents and young adults with chronic diseases need special care—and pediatric rheumatological conditions can persist into adulthood. Two new works presented at the 2025 congress of EULAR—The European Alliance of ...

Arthritis & Rheumatism

Study reveals risk factors for spinal deterioration in r-axSpA

Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic musculoskeletal disease that predominantly affects the axial skeleton. axSpA is an umbrella term that comprises the whole spectrum of patients with and without ...

Arthritis & Rheumatism

The value of physical activity for people with RMD

Regular physical activity is increasingly promoted for people with rheumatic and musculoskeletal diseases (RMD) as well as the general population. EULAR—The European Alliance of Associations for Rheumatology—has published ...

Arthritis & Rheumatism

Patient organizations: Supporting RMD patients with education

When receiving a diagnosis of a rheumatic musculoskeletal disease (RMD), people need a lot of information. Some need it all at once, while others may prefer to receive it in smaller portions or like to spread it out. This ...

Arthritis & Rheumatism

First data from the EULAR RheumaFacts project

Rheumatic and musculoskeletal diseases (RMD) are the leading causes of disability worldwide, resulting in significant health care and social support costs. One of the reasons for this increasing burden seems to be the variability ...

Arthritis & Rheumatism

Guidance needed for RMD patients seeking help online

Rheumatic musculoskeletal diseases (RMD) have an important impact on quality of life, and represent an economic burden to society. EULAR—The European Alliance of Associations for Rheumatology—has emphasized the role of ...

Arthritis & Rheumatism

Studies identify predictors and outcomes in systemic sclerosis

The Very Early Diagnosis of Systemic Sclerosis (VEDOSS) criteria identify red flags as puffy fingers, abnormal nailfold capillaroscopy, and specific autoantibodies in patients with Raynaud's phenomenon as a very early disease ...

Arthritis & Rheumatism

Healthy lifestyle cuts rheumatoid arthritis risk

(HealthDay)—A healthier lifestyle is associated with lower rheumatoid arthritis (RA) risk, according to a study published online Jan. 18 in Arthritis Care & Research.

Neuroscience

Researchers identify osteoarthritis 'pain pathway'

Researchers from North Carolina State University have discovered that a particular molecular signaling pathway plays an important role in producing osteoarthritis (OA) pain. Using a mouse model of painful osteoarthritis, ...

Medications

Newer rheumatoid arthritis drug might raise heart, cancer risks

(HealthDay)—Finding the right medication for rheumatoid arthritis isn't easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms.

Medications

Skyrizi approved for psoriatic arthritis

(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.

Arthritis & Rheumatism

Researchers develop new tool to help better monitor lupus

A new paper in Rheumatology, published by Oxford University Press, indicates that researchers have developed a new, easier, and more accurate tool to measure the progress of lupus in patients.

Arthritis & Rheumatism

Arthritis & the COVID vaccine: What you need to know

(HealthDay)—Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.

Arthritis & Rheumatism

How we walk could impact future arthritis

A new study suggests a person's walking style that places more pressure on the hips and knees can contribute to future osteoarthritis. Researchers say the key is to find and catch these habits 'in the act' early on.

Arthritis & Rheumatism

Are cortisone injections good or bad for arthritic knees?

(HealthDay)—Cortisone injections have gotten a bad rap in recent years as a treatment for arthritis pain, because steroids are known to damage cartilage and could potentially cause the joint to further deteriorate.